ZA200708700B - Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) - Google Patents

Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Info

Publication number
ZA200708700B
ZA200708700B ZA200708700A ZA200708700A ZA200708700B ZA 200708700 B ZA200708700 B ZA 200708700B ZA 200708700 A ZA200708700 A ZA 200708700A ZA 200708700 A ZA200708700 A ZA 200708700A ZA 200708700 B ZA200708700 B ZA 200708700B
Authority
ZA
South Africa
Prior art keywords
tfpi
administration
treatment
tissue factor
pathway inhibitor
Prior art date
Application number
ZA200708700A
Other languages
English (en)
Inventor
Creasey Abla
Original Assignee
Novartis Vaccines & Diagnostic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Vaccines & Diagnostic filed Critical Novartis Vaccines & Diagnostic
Publication of ZA200708700B publication Critical patent/ZA200708700B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA200708700A 2005-04-15 2008-10-11 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI) ZA200708700B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67146605P 2005-04-15 2005-04-15

Publications (1)

Publication Number Publication Date
ZA200708700B true ZA200708700B (en) 2008-12-31

Family

ID=36951247

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200708700A ZA200708700B (en) 2005-04-15 2008-10-11 Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)

Country Status (13)

Country Link
EP (1) EP1871408A2 (xx)
JP (1) JP2008536859A (xx)
KR (1) KR20080033151A (xx)
CN (1) CN101180074A (xx)
AU (1) AU2006236698A1 (xx)
BR (1) BRPI0610549A2 (xx)
CA (1) CA2605057A1 (xx)
IL (1) IL186548A0 (xx)
MX (1) MX2007012619A (xx)
RU (1) RU2007142192A (xx)
TN (1) TNSN07386A1 (xx)
WO (1) WO2006113360A2 (xx)
ZA (1) ZA200708700B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009129164A1 (en) * 2008-04-15 2009-10-22 Novartis Ag Pharmaceutical combinations of tfpi-fragments and an antibiotic

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0501111A2 (en) * 2001-10-15 2007-12-28 Chiron Corp Treatment of severe pneumonia by administration of tissue factor pathway inhibitor

Also Published As

Publication number Publication date
CN101180074A (zh) 2008-05-14
EP1871408A2 (en) 2008-01-02
CA2605057A1 (en) 2006-10-26
JP2008536859A (ja) 2008-09-11
MX2007012619A (es) 2008-01-11
WO2006113360A3 (en) 2007-04-12
KR20080033151A (ko) 2008-04-16
IL186548A0 (en) 2008-01-20
BRPI0610549A2 (pt) 2010-07-06
TNSN07386A1 (en) 2009-03-17
WO2006113360A2 (en) 2006-10-26
AU2006236698A1 (en) 2006-10-26
RU2007142192A (ru) 2009-05-20

Similar Documents

Publication Publication Date Title
HRP20181095T1 (hr) Monoklonska protutijela protiv inhibitora puta tkivnog faktora (tfpi)
EP2559388B8 (en) Endoscopic delivery of medical devices
IL187111A0 (en) Use of tfpi to treat severe bacterial infections
BRPI0721213A2 (pt) "regime de dosagem de inibidores da comt"
HK1128026A1 (en) Hydrobenzamide derivatives as inhibitors of hsp90
DK1837019T3 (da) Orale dispergerbare farmaceutiske sammensætninger
IL193252A0 (en) N-hydroxyacrylamide compounds
ZA200704392B (en) Antibiotic combinations for providing total solution to the treatment of infections
WO2008026156A3 (en) Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor
HUP0501111A2 (en) Treatment of severe pneumonia by administration of tissue factor pathway inhibitor
NO20085051L (no) Behandling av gastrointestinale forstyrrelser med CGRP-antagonister
IL178115A0 (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (tfpi)
IL182055A0 (en) Agent for prophylaxis or treatment of metabolic syndrome
ZA200708700B (en) Treatment of severe community-acquired pneumonia by administration of tissue factor pathway inhibitor (TFPI)
EP1951194A4 (en) TREATMENT OF ORAL HYGIENE WITH ANTIMICROBIAL DECAPEPTIDES
GB0428218D0 (en) Medicament for Treatment of Inflammatory Diseases
WO2007139948A3 (en) Imidazoazepinone compounds
MA30730B1 (fr) Traitement de la pneumonie extra-hospitaliere grave par administration de l'inhibiteur de parcours de facteur tissu (tfpi)
AU2006905588A0 (en) "Rake n' scrub" medical treatment
TWI350171B (en) Pharmaceutical compositions for treatment of cardio-cerebral-vascular diseases
ITMI20020755A1 (it) Composizioni farmaceutica topica per il trattamento della scabbia
IL182987A0 (en) Treatment of inflammation
GB0509298D0 (en) Treatment of inflammation